Improved production of the recombinant phospholipase A1 from wasp venom expressed in bacterial cells for use in routine diagnostics.

Amilcar Perez-Riverol, Alexis Musacchio-Lasa, Luis Gustavo Romani Fernandes, Jose Roberto Aparecido Dos Santos-Pinto, Franciele Grego Esteves, Murilo Luiz Bazon, Ricardo de Lima Zollner, Mario Sergio Palma, Márcia Regina Brochetto-Braga
Author Information
  1. Amilcar Perez-Riverol: 1Center for the Study of Social Insects, Department of General and Applied Biology, University of Sao Paulo State (UNESP/RC), São Paulo, Brazil.
  2. Alexis Musacchio-Lasa: 2Center for Genetic Engineering and Biotechnology. Biomedical Research Division, System Biology Department, Ave. 31, e/ 158 and 190, Cubanacan, Playa, P.O. Box 6162, 10600 Havana, Cuba.
  3. Luis Gustavo Romani Fernandes: 3Laboratory of Translational Immunology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.
  4. Jose Roberto Aparecido Dos Santos-Pinto: 1Center for the Study of Social Insects, Department of General and Applied Biology, University of Sao Paulo State (UNESP/RC), São Paulo, Brazil.
  5. Franciele Grego Esteves: 1Center for the Study of Social Insects, Department of General and Applied Biology, University of Sao Paulo State (UNESP/RC), São Paulo, Brazil.
  6. Murilo Luiz Bazon: 4Arthropod Molecular Biology Laboratory-LBMA-IB, University of Sao Paulo State (UNESP/RC), Ave. 24-A, 1515- Bela Vista, Rio Claro, SP 13506-900 Brazil.
  7. Ricardo de Lima Zollner: 3Laboratory of Translational Immunology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.
  8. Mario Sergio Palma: 1Center for the Study of Social Insects, Department of General and Applied Biology, University of Sao Paulo State (UNESP/RC), São Paulo, Brazil.
  9. Márcia Regina Brochetto-Braga: 4Arthropod Molecular Biology Laboratory-LBMA-IB, University of Sao Paulo State (UNESP/RC), Ave. 24-A, 1515- Bela Vista, Rio Claro, SP 13506-900 Brazil. ORCID

Abstract

Phospholipase A1 (PLA1) is one of the three major allergens identified in the venom of (Hymenoptera: Vespidae), a clinically relevant wasp from southeastern Brazil. The recombinant form of this allergen (rPoly p 1) could be used for the development of molecular diagnostic of venom allergy. Early attempts to produce rPoly p 1 using BL21 (DE3) cells rendered high yields of the insoluble rPoly p 1 but with low levels of solubilized protein recovery (12%). Here, we aimed to improve the production of rPoly p 1 in by testing different conditions of expression, solubilization of the inclusion bodies and protein purification. The results showed that the expression at 16 °C and 0.1 mM of IPTG increased the production of rPoly p 1, still in the insoluble form, but with high solubilized protein yields after incubation with citrate-phosphate buffer with 0.15 M NaCl, 6 M urea, pH 2.6 at 25 ºC for 2 h. The venom allergen was also cloned in pPICZαA vector for soluble expression as a secreted protein in X-33 cells, rendering almost undetectable levels (nanograms) in the culture supernatant. In contrast, a sevenfold increase of the solubilized and purified rPoly p 1 yields (1.5 g/L of fermentation broth) was obtained after improved production in . The identity of the protein was confirmed with an anti-His antibody and MS spectra. Allergen-specific IgE (sIgE)-mediated recognition was evaluated in immunoblotting with sera of allergic patients ( = 40). Moreover, rPoly p 1 showed high levels of diagnostic sensitivity (95%). The optimized strategy for rPoly p 1 production described here, will provide the amounts of allergen necessary for the subsequent protein refolding, immunological characterization steps, and ultimately, to the development of molecular diagnostic for venom allergy.

Keywords

References

  1. J Immunol. 2010 May 1;184(9):5403-13 [PMID: 20348419]
  2. Appl Microbiol Biotechnol. 2011 Apr;90(1):69-76 [PMID: 21181153]
  3. Glycoconj J. 1995 Feb;12(1):77-83 [PMID: 7795417]
  4. Toxins (Basel). 2015 Jul 09;7(7):2551-70 [PMID: 26184309]
  5. Protein Expr Purif. 2000 Mar;18(2):182-92 [PMID: 10686149]
  6. Curr Opin Allergy Clin Immunol. 2017 Oct;17(5):363-372 [PMID: 28759475]
  7. Protein Expr Purif. 2013 Feb;87(2):129-35 [PMID: 23168094]
  8. Acta Crystallogr D Biol Crystallogr. 2006 Jun;62(Pt 6):595-604 [PMID: 16699186]
  9. Insect Biochem Mol Biol. 2019 Feb;105:10-24 [PMID: 30582958]
  10. Protein Expr Purif. 2012 Mar;82(1):240-51 [PMID: 22085722]
  11. Biotechnol Adv. 2015 Nov 1;33(6 Pt 2):1177-93 [PMID: 26027890]
  12. Biochim Biophys Acta. 1992 Dec 2;1165(2):201-10 [PMID: 1450215]
  13. Front Immunol. 2014 Feb 28;5:77 [PMID: 24616722]
  14. Protein Expr Purif. 2015 Apr;108:62-72 [PMID: 25659501]
  15. Microb Cell Fact. 2009 May 14;8:26 [PMID: 19442264]
  16. Protein Expr Purif. 2016 Oct;126:115-121 [PMID: 27335160]
  17. Nature. 1970 Aug 15;227(5259):680-5 [PMID: 5432063]
  18. Protein Pept Lett. 2012 Jun 1;19(6):625-35 [PMID: 22519534]
  19. Protein Expr Purif. 2016 Nov;127:73-80 [PMID: 27412717]
  20. Methods Mol Biol. 2015;1258:1-24 [PMID: 25447856]
  21. J Allergy Clin Immunol. 2014 May;133(5):1383-9, 1389.e1-6 [PMID: 24440283]
  22. Adv Pharm Bull. 2015 Nov;5(4):455-61 [PMID: 26819916]
  23. J Allergy Clin Immunol. 2011 Jul;128(1):247-8; author reply 248 [PMID: 21439627]
  24. J Allergy Clin Immunol. 2012 May;129(5):1406-8 [PMID: 22277201]
  25. Clin Exp Allergy. 2018 Apr;48(4):354-364 [PMID: 29331065]
  26. PLoS One. 2011;6(6):e21267 [PMID: 21731687]
  27. Allergy. 2009 Apr;64(4):543-8 [PMID: 19120073]
  28. Allergy. 2012 Apr;67(4):528-36 [PMID: 22229815]
  29. Toxicon. 2018 Jun 15;148:172-196 [PMID: 29715467]
  30. Biotechnol J. 2012 May;7(5):620-34 [PMID: 22442034]
  31. J Allergy Clin Immunol. 2011 Sep;128(3):671-3 [PMID: 21481443]
  32. Toxicon. 2007 Dec 1;50(7):923-37 [PMID: 17761205]
  33. Methods Mol Biol. 2015;1258:27-44 [PMID: 25447857]
  34. Clin Mol Allergy. 2010 Apr 01;8:7 [PMID: 20359368]
  35. Curr Allergy Asthma Rep. 2015 May;15(5):26 [PMID: 26139335]
  36. J Proteome Res. 2014 Feb 7;13(2):855-65 [PMID: 24308509]
  37. Protein Expr Purif. 2017 Feb;130:35-43 [PMID: 27350535]
  38. Anal Biochem. 1985 Oct;150(1):76-85 [PMID: 3843705]
  39. Springerplus. 2013 Dec;2(1):89 [PMID: 23525091]
  40. Biotechnol Bioeng. 2007 Apr 15;96(6):1101-6 [PMID: 17013944]
  41. Toxicon. 2016 Dec 15;124:44-52 [PMID: 27826019]
  42. Inflamm Allergy Drug Targets. 2011 Oct;10(5):420-8 [PMID: 21756243]
  43. J Allergy Clin Immunol. 1998 May;101(5):691-8 [PMID: 9600508]
  44. J Proteomics. 2017 May 24;161:88-103 [PMID: 28435107]
  45. Clin Exp Allergy. 2013 Feb;43(2):255-61 [PMID: 23331567]
  46. Protein Expr Purif. 2012 Apr;82(2):297-301 [PMID: 22333528]
  47. PLoS One. 2013;8(2):e56582 [PMID: 23451057]
  48. BMC Biotechnol. 2007 Jun 12;7:32 [PMID: 17565681]

Word Cloud

Created with Highcharts 10.0.01rPolypproteinvenomproductionA1allergendiagnosticallergycellshighyieldslevelssolubilizedexpressionwasprecombinantformdevelopmentmolecularinsolubleshowed0phospholipasediagnosticsPhospholipasePLA1onethreemajorallergensidentifiedHymenoptera:VespidaeclinicallyrelevantsoutheasternBrazilusedEarlyattemptsproduceusingBL21DE3renderedlowrecovery12%aimedimprovetestingdifferentconditionssolubilizationinclusionbodiespurificationresults16°C1 mMIPTGincreasedstillincubationcitrate-phosphatebuffer15 MNaCl6 MureapH2625ºC2 halsoclonedpPICZαAvectorsolublesecretedX-33renderingalmostundetectablenanogramsculturesupernatantcontrastsevenfoldincreasepurified5 g/Lfermentationbrothobtainedimprovedidentityconfirmedanti-HisantibodyMSspectraAllergen-specificIgEsIgE-mediatedrecognitionevaluatedimmunoblottingseraallergicpatients = 40Moreoversensitivity95%optimizedstrategydescribedwillprovideamountsnecessarysubsequentrefoldingimmunologicalcharacterizationstepsultimatelyImprovedexpressedbacterialuseroutineMolecularPolybiapaulistaRecombinantRecoverySolubilizationVenom

Similar Articles

Cited By